SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pharmos (PARS)
An SI Board Since October 1998
Posts SubjectMarks Bans Symbol
1386 42 0 PARS
Emcee:  Dr. John M. de Castro Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
761 Hi Yosi I agree with Ron, that unless you have very strong figures (+30-40 % iRichard Huth-5/8/1999
760 Yosi, thank you for the reply post. I do not expect an announcement of a partnRon-5/7/1999
759 Conference call Tuesday. For further detail will await Monday.yosi s-5/7/1999
758 when and what are the details of the conference call david David Israel-Rosen-5/7/1999
757 That is where you are wrong. If Q1 number are consistent with projected growth yosi s-5/7/1999
756 The first Quarter will not have a positive affect on the stock price unless theRon-5/7/1999
755 Q1 report Monday before market open. yosi s-5/7/1999
754 Q1 reports Friday, or Monday.yosi s-5/6/1999
753 Hi Yosi, Well technically speaking PARS needs a few days of said volume to makBRAVEHEART-5/4/1999
752 Nice volume, nice reversal. Technically this may be a key reversal...... Finallyosi s-5/4/1999
751 Any ideas on stock price increase? Ron-5/4/1999
750 The following are the retail prices from an online pharmacy.... yosi s-5/4/1999
749 Alrex and Lotemax avoids side effect due to increased intra occular pressure. (yosi s-5/4/1999
748 yosi- it was my recollection that lot/alrex avoided much of the side effects seTony van Werkhooven-5/4/1999
747 Safety issue is due to being a corticosteroids, not specific to Alrex and Lotyosi s-5/4/1999
746 Schlepper...do you have an idea what the "safety" concerns are? DoesRon-5/4/1999
745 The safety profiles for Alrex and Lotemax are not known by those who provide caShlepper-5/3/1999
744 Yosi: Your sales guess is just about where I am; up some 15% from the prior Q. arnie h-5/3/1999
743 Interesting though, that they're lower than at any point in (at least) the hawkshaw27-5/3/1999
742 Revenues to PARS 250-300k,for Q1 My guess. onlyyosi s-4/29/1999
741 Its interesting that people on the thread are willing to estimate earnings and arnie h-4/29/1999
740 PARS Short Interest remains stable Month Shares Short Avg Daily Volume RatiDr. John M. de Castro-4/28/1999
739 The more studies there are the better it looks.. Of importance is that it was gyosi s-4/28/1999
738 Dexanabinol; a novel neuroprotective drug in experimental focal cerebral ischemDr. John M. de Castro-4/28/1999
737 Yosi et al: Anybody willing to take a guess on how Alrex and Lotemax sales werearnie h-4/27/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News